US Patent 9562012 PPAR-sparing compounds for the treatment of metabolic diseases
Patent 9562012 was granted and assigned to Metabolic Solutions Development Company on February, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9562012 PPAR-sparing compounds for the treatment of metabolic diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.